-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Initiates Coverage On Design Therapeutics with Overweight Rating, Announces Price Target of $26

Benzinga·10/02/2026 14:23:01
語音播報
Wells Fargo analyst Tianqi Hang initiates coverage on Design Therapeutics (NASDAQ:DSGN) with a Overweight rating and announces Price Target of $26.